We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sexual Functioning in Endometrial Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00543192
First Posted: October 12, 2007
Last Update Posted: October 2, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Wisconsin, Madison
  Purpose
The purpose of this study is estimate how sexual function in endometrial cancer survivors varies with severity of disease.

Condition
Endometrial Cancer Sexual Function

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Sexual Functioning in Endometrial Cancer Survivors

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Female Sexual Function Index (FSFI). [ Time Frame: at time of enrollment ]

Enrollment: 73
Study Start Date: October 2007
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
University of Wisconsin Gynecologic Oncology and Radiation Oncology Clinics
Criteria

Inclusion Criteria:

  • History of Stage I-IIIA endometrial adenocarcinoma of any grade
  • 1-5 years out from primary surgical treatment
  • Adjuvant therapy may only have consisted of radiation or hormonal therapy
  • No evidence of disease

Exclusion Criteria:

  • Previous treatment for other malignancies
  • Did not undergo surgery for primary treatment of endometrial cancer
  • Inability to read, write and speak fluent English
  • Major cognitive impairment affecting ability to provide consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00543192


Locations
United States, Wisconsin
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: David M Kushner, MD University of Wisconsin, Madison
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00543192     History of Changes
Other Study ID Numbers: CC 07703
H-2007-0204
First Submitted: October 10, 2007
First Posted: October 12, 2007
Last Update Posted: October 2, 2015
Last Verified: September 2009

Keywords provided by University of Wisconsin, Madison:
Endometrial Cancer
Sexual Function

Additional relevant MeSH terms:
Endometrial Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Diseases
Genital Diseases, Female